Vimarsana
Biggest News Aggregation in the World

Nick Colangelo News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nick Colangelo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nick Colangelo Today - Breaking & Trending Today

Vericel to Present at the Leerink Partners Healthcare Crossroads Conference on Wednesday, May 29, 2024 - Vimarsana News

Vericel to Present at the Leerink Partners Healthcare Crossroads Conference on Wednesday, May 29, 2024

CAMBRIDGE, Mass., May 22, 2024 -- Vericel Corporation , a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President and CEO...

Here's Why Shareholders May Want To Be Cautious With Increasing Vericel Corporation's (NASDAQ:VCEL) CEO Pay Packet - Vimarsana News

Here's Why Shareholders May Want To Be Cautious With Increasing Vericel Corporation's (NASDAQ:VCEL) CEO Pay Packet

Key Insights Vericel's Annual General Meeting to take place on 1st of May Salary of US$790.0k is part of CEO Nick...

Source: yahoo.com
Vericel Corp (VCEL) Reports Robust Revenue and EBITDA Growth in Q4 and Full-Year 2023 - Vimarsana News

Vericel Corp (VCEL) Reports Robust Revenue and EBITDA Growth in Q4 and Full-Year 2023

Company Provides Positive Outlook with Strong 2024 Revenue and EBITDA Margin Guidance

Source: yahoo.com
Vericel Reports Fourth Quarter and Full-Year 2023 Financial - Vimarsana News

Vericel Reports Fourth Quarter and Full-Year 2023 Financial

Full-Year 2023 Total Revenue Growth of 20% to $197.5 Million, with Adjusted EBITDA Growth of 40% Fourth Quarter Total Revenue Growth of 23% to $65.0...

Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance - Vimarsana News

Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance

Full-Year 2023 Total Revenue Growth of 20% to $197.5 Million, with Adjusted EBITDA Growth of 40% Fourth Quarter Total Revenue Growth of 23% to $65.0 Million, with Adjusted EBITDA Growth of 50% ...